Page last updated: 2024-11-12
fungiqual
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
fungiqual: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 14422805 |
MeSH ID | M0169683 |
Synonyms (38)
Synonym |
---|
12224-02-1 |
tetrasodium 4,4'-bis((4-(bis(2-hydroxyethyl)amino)-6-((3-sulphonatophenyl)amino)-1,3,5-triazin-2-yl)amino)stilbene-2,2'-disulphonate |
fungiqual |
belofor stsd |
c.i. fluorescent brightenening agent 24 |
heliofor p |
whitex bb |
c.i. fluorescent brightener 24 |
einecs 235-422-6 |
tinopal 2b |
kayaphor bsn |
tinopal 2bf |
mikephor bn |
benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis(5-((4-(bis(2-hydroxyethyl)amino)-6-((3-sulfophenyl)amino)-1,3,5-triazin-2-yl)amino)-, tetrasodium salt |
c.i. fluorescent brightening agent 24 |
4,4'-bis(di-(2-hydroxyethyl)amino-4-(3-sulfophenylamino)-1,3,5-triazine-6-ylamino)-stilbene-2,2'-disulfonic acid |
benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis(5-((4-(bis(2-hydroxyethyl)amino)-6-((3-sulfophenyl)amino)-1,3,5-triazin-2-yl)amino)-, sodium salt (1:4) |
unii-0419jut1k5 |
0419jut1k5 , |
benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-[bis(2-hydroxyethyl)amino]-6-[(3-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, tetrasodium salt |
AKOS024428305 |
fluorescent brightening agent 24 |
12768-91-1 |
fluorescent brightener 87 |
tetrasodium 4,4'-bis[[4-[bis(2-hydroxyethyl)amino]-6-[(3-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate |
W-110295 |
fluorescent brightener 24 |
4,4'-bis4-bis(2-hydroxyethyl)amino-6-(3-sulphonatophenyl)amino-1,3,5-triazin-2-ylaminostilbene-2,2'-disulphonate (sodium salt) |
ci fluorescent brightening agent 24 |
ci fluorescent brightener 24 |
60317-05-7 |
4,4'-bis(4-(3-sulfoanilino)-6-(bis(2-hydroxyethyl)amino)-1,3,5-triazin-2-yl)aminostilbene-2,2'-disulfonic acid tetrasodium salt |
2,2'-stilbenedisulfonic acid, 4,4'-bis((4-(bis(2-hydroxyethyl)amino)-6-(m-sulfoanilino)-s-triazin-2-yl)amino)-, tetrasodium salt |
tetrasodium;5-[[4-[bis(2-hydroxyethyl)amino]-6-(3-sulfonatoanilino)-1,3,5-triazin-2-yl]amino]-2-[(e)-2-[4-[[4-[bis(2-hydroxyethyl)amino]-6-(3-sulfonatoanilino)-1,3,5-triazin-2-yl]amino]-2-sulfonatophenyl]ethenyl]benzenesulfonate |
Q27247600 |
1ST8401 |
c.i. fluorescent brightener 87 |
fluorescent brightener 24 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (4)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.74
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.74) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |